Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts

Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial disease (PAD), is the main cause of death, with an annual mortality incidence predicted to rise to 23.3 million worldwide by 2030. Current revascularization techniques consist of angioplasty, placement of a st...

Full description

Bibliographic Details
Published in:Frontiers in Bioengineering and Biotechnology
Main Authors: Michele Carrabba, Paolo Madeddu
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Subjects:
tissue engineering
vascular conduits
myocardial ischemia
regenerative medicine
stem cells
Online Access:http://journal.frontiersin.org/article/10.3389/fbioe.2018.00041/full

Similar Items

Similar Items